IRIS
CAMPIANI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.746
EU - Europa 14.232
AS - Asia 2.439
AF - Africa 77
SA - Sud America 29
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 13
Totale 32.562
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.674
GB - Regno Unito 4.113
IE - Irlanda 2.300
IT - Italia 1.934
CN - Cina 1.655
UA - Ucraina 1.224
SE - Svezia 1.199
RU - Federazione Russa 1.050
DE - Germania 936
FR - Francia 668
SG - Singapore 426
FI - Finlandia 404
TR - Turchia 157
ES - Italia 98
CA - Canada 65
CZ - Repubblica Ceca 54
CI - Costa d'Avorio 51
BE - Belgio 47
IN - India 43
AT - Austria 37
IR - Iran 28
NL - Olanda 28
VN - Vietnam 27
GR - Grecia 26
RO - Romania 25
AU - Australia 22
PL - Polonia 13
PT - Portogallo 13
EU - Europa 12
JP - Giappone 12
CL - Cile 9
LV - Lettonia 9
NG - Nigeria 9
BR - Brasile 8
EG - Egitto 8
HU - Ungheria 7
ID - Indonesia 7
IL - Israele 7
KR - Corea 7
LA - Repubblica Popolare Democratica del Laos 7
SA - Arabia Saudita 7
AZ - Azerbaigian 6
CH - Svizzera 6
HK - Hong Kong 6
PA - Panama 6
BD - Bangladesh 5
BG - Bulgaria 5
EE - Estonia 5
PK - Pakistan 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
DK - Danimarca 4
MY - Malesia 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
PE - Perù 4
RS - Serbia 4
AL - Albania 3
HR - Croazia 3
KG - Kirghizistan 3
KH - Cambogia 3
KW - Kuwait 3
LT - Lituania 3
MA - Marocco 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
AR - Argentina 2
BO - Bolivia 2
BY - Bielorussia 2
CO - Colombia 2
GE - Georgia 2
IM - Isola di Man 2
KZ - Kazakistan 2
LK - Sri Lanka 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
EC - Ecuador 1
GH - Ghana 1
IQ - Iraq 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
MC - Monaco 1
MD - Moldavia 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TM - Turkmenistan 1
TW - Taiwan 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 32.562
Salva come PNG Salva come JPEG
Città #
Southend 3.822
Fairfield 2.762
Dublin 2.281
Ashburn 1.469
Chandler 1.250
Woodbridge 1.196
Jacksonville 1.006
Seattle 984
Wilmington 979
Cambridge 926
Houston 909
Siena 787
Ann Arbor 654
Princeton 396
Beijing 375
Nanjing 345
Singapore 333
Boardman 181
Dearborn 164
Fremont 156
Helsinki 149
San Diego 136
Izmir 134
New York 133
Nanchang 127
Shanghai 125
Moscow 119
Florence 114
San Mateo 90
Washington 81
Menlo Park 77
Málaga 77
Shenyang 69
Hebei 68
Lappeenranta 64
Jiaxing 57
Kunming 57
Rome 56
Venezia 55
Lancaster 54
Abidjan 51
Redwood City 51
Düsseldorf 50
Milan 50
London 45
Brno 43
Tianjin 43
Brussels 42
Ningbo 41
Changsha 40
Jinan 40
Norwalk 39
Los Angeles 38
Aachen 34
Guangzhou 31
Munich 30
Vienna 30
San Francisco 26
Ottawa 25
Toronto 24
Dong Ket 23
Frankfurt am Main 22
Hangzhou 22
Hanover 21
Hefei 19
Philadelphia 19
Zhengzhou 18
Turin 17
Prato 16
Parma 15
Pisa 15
Timisoara 15
Avellino 14
Salerno 14
Taizhou 14
Marietta 12
Rende 12
San Giovanni Valdarno 12
Changchun 11
Columbus 11
Amsterdam 10
Dallas 10
Lanzhou 10
Leawood 10
Mestre 10
Palermo 10
Arezzo 9
Bologna 9
Fisciano 9
Haikou 9
Lastra a Signa 9
Maletto 9
Naples 9
Riga 9
Santa Clara 9
Borgo San Lorenzo 8
Catanzaro 8
Kilburn 8
Lagos 8
Padova 8
Totale 24.093
Salva come PNG Salva come JPEG
Nome #
Development of Potent Inhibitors of the Mycobacterium tuberculosis Virulence Factor Zmp1 and Evaluation of Their Effect on Mycobacterial Survival inside Macrophages 294
Development of novel cyclic peptides as pro-apoptotic agents 273
Structure-activity relationships, biological evaluation and structural studies of novel pyrrolonaphthoxazepines as antitumor agents 270
Antimalarial agents against both sexual and asexual parasites stages: structure-activity relationships and biological studies of the Malaria Box compound 1-[5-(4-bromo-2-chlorophenyl)furan-2-yl]- N -[(piperidin-4-yl)methyl]methanamine (MMV019918) and analogues 263
(S)-2-Amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)propanoic Acid (AMPA) and Kainate Receptor Ligands: further exploration of bioisosteric replacements and structural and biological investigation 257
iPSC-derived neurons profiling reveals GABAergic circuit disruption and acetylated α-tubulin defect which improves after iHDAC6 treatment in Rett syndrome 250
Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain 249
Novel spiroindoline HDAC inhibitors: Synthesis, molecular modelling and biological studies 230
Synthetic spirocyclic endoperoxides: new antimalarial scaffolds 227
A new microtubule-targeting compound PBOX-15 inhibits T-cell migration via post-translational modifications of tubulin 222
The 1-(2,3-dichlorophenyl)-piperazine-to-aripiprazole ratio at steady state in rats and schizophrenic patients 220
First dual AK/GSK-3β inhibitors endowed with antioxidant properties as multifunctional, potential neuroprotective agents 216
Bridged bicyclic 2,3-dioxabicyclo[3.3.1]nonanes as antiplasmodial agents: Synthesis, structure-activity relationships and studies on their biomimetic reaction with Fe(II) 215
Development of Potent Inhibitors of Fatty Acid Amide Hydrolase Useful for the Treatment of Neuropathic Pain 213
Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems 212
Natural Compounds and Synthetic Drugs to Target FAAH Enzyme 212
Synthesis, Molecular Modelling and Biological Studies of 3-hydroxy-pyrane-4-one and 3-hydroxy-pyridine-4-one Derivatives as HIV-1 Integrase Inhibitors 211
Old but gold: tracking the new guise of Histone Deacetylase 6 (HDAC6) enzyme as a biomarker and therapeutic target in rare diseases 211
Targeting Dopamine D3and Serotonin 5-HT1Aand 5-HT2AReceptors for Developing Effective Antipsychotics: Synthesis, Biological Characterization, and Behavioral Studies 200
Identification of novel fluorescent probes preventing PrP(Sc) replication in prion diseases 199
A Jocic-type approach for a practical and scalable synthesis of pyrrolonaphthoxazepine (PNOX)-based potent proapoptotic agents 199
Activation of the Wnt pathway by small peptides: rational design, synthesis and biological evaluation 198
Structure-based discovery of the first non-covalent inhibitors of Leishmania major tryparedoxin peroxidase by high throughput docking 197
null 195
Discovery of a new class of potential multifunctional atypical antipsychotic agents targeting dopamine d3 and serotonin 5-HT 1A and 5-HT2A receptors: Design, synthesis, and effects on behavior 188
Structural characterization of Giardia duodenalis thioredoxin reductase (gTrxR) and computational analysis of its interaction with NBDHEX 186
Targeting clinically-relevant metallo-β-lactamases: from high-throughput docking to broad-spectrum inhibitors 185
Selective Kainate Receptor (GluK1) Ligands Structurally Based upon 1H-Cyclopentapyrimidin-2,4(1H,3H)-dione: Synthesis, Molecular Modeling, and Pharmacological and Biostructural Characterization 184
A stereoselective route to 6-substituted pyrrolo-1,5-benzoxazepinones and their analogues 183
Cinnamic acids derived compounds with antileishmanial activity target Leishmania amazonensis arginase 183
1H-Cyclopentapyrimidine-2,4(1H,3H)-dione-Related Ionotropic Glutamate Receptors Ligands. Structure-Activity Relationships and Identification of Potent and Selective iGluR5 Modulators 180
Optimization of 4-Aminoquinoline/Clotrimazole-Based Hybrid Antimalarials: Further Structure-Activity Relationships, in vivo Studies, and Preliminary Toxicity Profiling 178
Synthesis and structure-activity relationship studies in serotonin 5-HT4 receptor ligands based on a benzo[de][2,6]naphthridine scaffold 176
Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease 174
Synthetic studies toward 1,2-dioxanes as precursors of potential endoperoxide-containing antimalarials 173
Telomerase-based cancer therapeutics: a review on their clinical trials 173
The FAAH inhibitor URB597 suppresses hippocampal maximal dentate afterdischarges and restores seizure-induced impairment of short and long-term synaptic plasticity 171
Discovery of Potent Inhibitors of Human and Mouse Fatty Acid Amide Hydrolases 171
Non-Nucleoside Inhibitors of Human Adenosine Kinase: Synthesis, Molecular Modeling, and Biological Studies 169
Pyrrolo 1,3 benzothiazepine-based Atypical Antipsychotic Agents. Synthesis, Structure-Activity Relationship, Molecular Modeling, and Biological Studies 169
A light in the dark: State of the art and perspectives in optogenetics and optopharmacology for restoring vision 169
Discovery of Bishomo(hetero)arylpiperazines as Novel Multifunctional Ligands Targeting Dopamine D-3 and Serotonin 5-HT1A and 5-HT2A Receptors 168
Cardiovascular Characterization of Pyrrolo[2,1-d][1,5]benzothiazepine Derivatives Binding Selectively to the Peripheral-Type Benzodiazepine Receptor (PBR):  From Dual PBR Affinity and Calcium Antagonist Activity to Novel and Selective Calcium Entry Blockers 168
Synthesis and Antiplasmodial Activity of Bicyclic Dioxanes as Simplified Dihydroplakortin Analogues 166
Exploiting Protein Fluctuations at the Active-Site Gorge of Human Cholinesterases: Further Optimization of the Design Strategy to Develop Extremely Potent Inhibitors 165
Novel Ligands Specific for Mitochondrial Benzodiazepine Receptors: 6-arylpyrrolo[2,1-d][1,5]benzothiazepine Derivatives. Synthesis, Structure-Activity Relationships, and Molecular Modeling Studies 165
Design and Synthesis of Potent Antimalarial Agents Based on Clotrimazole Scaffold: Exploring an Innovative Pharmacophore 165
Mimicking the Intramolecular Hydrogen Bond: Synthesis, Biological Evaluation, and Molecular Modeling of Benzoxazines and Quinazolines as Potential Antimalarial Agents 165
Synthesis and structure–activity relationship studies in serotonin 5-HT1A receptor agonists based on fused pyrrolidone scaffolds 165
Microwave-assisted synthesis of 4-quinolylhydrazines followed by nickel boride reduction: a convenient approach to 4-aminoquinolines and derivatives 164
A synthetic strategy to bridged 2,3,8-trioxabicyclo[3,3,1]nonane endoperoxides 164
Synthesis of Dihydroplakortin, 6-epi-Dihydroplakortin, and Their C10-Desethyl Analogues 163
The Interactions of the 5-HT3 Receptor with Quipazine-Like Arylpiperazine Ligands. The Journey Track at the End of the First Decade of the Third Millennium 162
A stereoselective approach to peptidomimetic BACE1 inhibitors 162
Unravelling the response of chronic lymphocytic leukemia to a novel class of anticancer agents, the pyrrolonaphthoxazepines (PNOXs) 162
Quinolylhydrazones as novel inhibitors of Plasmodium falciparum serine protease PfSUB1 160
Synthetic studies toward bicyclic endoperoxides presenting polar side chains 160
Novel quinolone-based potent and selective HDAC6 inhibitors: synthesis, molecular modeling studies and biological investigation 159
Pyrroloquinoxaline Derivatives as High-Affinity and Selective 5-HT3 Receptor Agonists: Synthesis, Further Structure-Activity Relationships, and Biological Studies 157
ANTIMALARIAL AGENTS HAVING POLYAROMATIC STRUCTURE 157
Donepezil-like multifunctional agents: Design, synthesis, molecular modeling and biological evaluation 157
Endocannabinoid Modulation of Predator Stress-Induced Long-Term Anxiety in Rats 156
Dopamine D3 receptor antagonists as potential therapeutics for the treatment of neurological diseases 156
Diltiazem-like calcium entry blockers: a hypothesis of the receptor-binding site based on a comparative molecular field analysis model 154
Novel peptidomimetics as BACE-1 inhibitors: synthesis, molecular modeling, and biological studies 154
Pyrrolo[2,1-c][1,4]benzothiazines: Synthesis, Structure-Activity Relationships, Molecular Modeling Studies, and Cardiovascular Activity 153
Development of a multiplexed activity-based protein profiling assay to evaluate activity of endocannabinoid hydrolase inhibitors 153
A Concerted Study Using Binding Measurements, X-ray Structural Data, and Molecular Modeling on the Stereochemical Features Responsible for the Affinity of 6-Arylpyrrolo[2,1-d][1,5]benzothiazepines toward Mitochondrial Benzodiazepine Receptors 153
ARYL PIPERAZINE DERIVATIVES USEFUL FOR THE TREATMENT OF NEUROPSYCHIATRY DISORDERS. 152
Synthesis of N1-arylidene-N2-quinolyl- and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains 152
Development of piperazine-tethered heterodimers as potent antimalarials against chloroquine-resistant P. falciparum strains. Synthesis and molecular modeling 152
Development of Antitubercular Compounds Based on a 4-Quinolylhydrazone Scaffold. Further Structure-activity Relationship Studies 151
Design, synthesis, and structure-activity relationship studies of 4-quinolinyl- and 9-acrydinylhydrazones as potent antimalarial agents 151
Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability 151
New Antipsychotic Agents with Serotonin and Dopamine Antagonist Properties Based on a Pyrrolo[2,1-b][1,3]benzothiazepine Structure 150
A Comparative Molecular Field Analysis Model for 6-Arylpyrrolo[2,1-d][1,5]benzothiazepines Binding Selectively to the Mitochondrial Benzodiazepine Receptor 150
Raising the bar in anticancer therapy: recent advances in, and perspectives on, telomerase inhibitors 150
Pyrrolobenzoxazepinone Derivatives as Non-Nucleoside HIV-1 RT Inhibitors: Further Structure-Activity Relationship Studies and Identification of More Potent Broad-Spectrum HIV-1 RT Inhibitors with Antiviral Activity 148
A palladium-catalyzed synthetic approach to new Huperzine A analogues modified at the pyridone ring 148
Allosteric Modulation of Ionotropic Glutamate Receptors: An Outlook on New Therapeutic Approaches To Treat Central Nervous System Disorders 148
Quinoxalinylethylpyridylthioureas (QXPTs) as Potent Non-nucleoside HIV-1 Reverse Transcriptase (RT) Inhibitors. Further SAR Studies and Identification of a Novel Orally Bioavailable Hydrazine-Based Antiviral Agent 148
Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents 147
Development of molecular probes for the identification of extra interaction sites in the mid-gorge and peripheral sites of butyrylcholinesterase (BuChE). Rational design of novel, selective, and highly potent BuChE inhibitors 146
Malaria chemotherapy: recent advances in drug development 145
Novel aryl piperazine derivatives with medical utility 143
An approach to modified heterocyclic analogues of huperzine A and isohuperzine A. Synthesis of the pyrimidone and pyrazole analogues, and their anticholinesterase activity 143
Multifunctional Cholinesterase and Amyloid Beta Fibrillization Modulators. Synthesis and Biological Investigation 143
Pyrroloquinoxaline hydrazones as fluorescent probes for amyloid fibrils 142
Harnessing the role of HDAC6 in Idiopathic Pulmonary Fibrosis: design, synthesis, structural analysis, and biological evaluation of potent inhibitors 142
Pyrrolo[1,5]benzoxa(thia)zepines as a New Class of Potent Apoptotic Agents. Biological Studies and Identification of an Intracellular Location of Their Drug Target 141
Specific Targeting of Hepatitis C Virus NS3 RNA Helicase. Discovery of the Potent and Selective Competitive Nucleotide-Mimicking Inhibitor QU663 141
Discovery of Huperzine A/Tacrine Hybrids as Potent Inhibitors of Human Cholinesterases Targeting Their Mid-gorge Recognition Sites 137
Polycondensed heterocycles. IV. Synthesis of 1,4-Dioxo-2,3,3a,4-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzothiazine 137
Identification of tubulin as the molecular target of proapoptotic pyrrolo-1,5-benzoxazepines 137
Synthesis, Biological Activity, and SARs of Pyrrolobenzoxazepine Derivatives, a New Class of Specific “Peripheral-Type” Benzodiazepine Receptor Ligands 137
Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human astrocytoma cells by the pyrrolo-1,5-benzoxazepine, PBOX-21 136
A Straightforward Approach for Engineering Efficacy and Selectivity at GPCRs 136
Identification of a novel arylpiperazine scaffold for fatty acid amide hydrolase inhibition with improved drug disposition properties 136
Specific Targeting of Peripheral Serotonin 5-HT3 Receptors. Synthesis, Biological Investigation and Structure Activity Relationships 136
Synthesis and preliminary biological evaluation of 1-aminomethyl-4-substituted-4-H-pyrrolo[2,1-C][1,4] benzothiazines, a new class of calcium antagonists 135
Totale 17.389
Salva come PNG Salva come JPEG
Categoria #
all - tutte 105.725
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.725
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.168 0 0 0 0 456 603 612 801 553 572 163 408
2020/20215.596 239 500 254 515 364 874 383 693 516 557 440 261
2021/20223.544 302 526 243 194 174 82 200 140 170 437 390 686
2022/20234.785 284 398 635 661 534 960 117 387 427 135 157 90
2023/20243.997 157 81 351 177 214 1.084 1.234 69 34 119 139 338
2024/20251.957 197 342 859 392 167 0 0 0 0 0 0 0
Totale 33.206